Sirio Pharma Acquires European Softgel Manufacturer
Sirio specializes in delivery forms such as softgels, capsules, tablets, powders, gummies, and liquids.
Photo © iStockphoto.com/suleo
Contract manufacturer Sirio Pharma Company, Ltd., (Shantou, China) has acquired European softgel manufacturer Ayanda GmbH. Sirio specializes in delivery forms such as softgels, capsules, tablets, powders, gummies, and liquids.
“Ayanda’s good reputation and production capacity in Europe will help Sirio to establish a global development and production service system,” said Sirio in a press release. “At the same time, Ayanda will also benefit from the multi-dosage-form production capacity of Sirio, creating more value for customers in the European market. Sirio and Ayanda will work together to integrate our collective production, service, and products. Together we complement each other’s advantages, and create much better values for customers.”
Sirio says it is approved via the following: TGA-GMP, NPA/UL GMP, BRC, UL’s Management System, 21 CFR Part 111, ISO 9001:2015 certification.
Also read:
Capsule and Softgel Advancements for Dietary Supplements
Softgel Benefits for Dietary Supplements
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
